Aikya

What Aikya does

Aikya Pharmaceutical Joint Stock Company is a vertically integrated Vietnamese pharmaceutical group established in 2016 and headquartered at Bitexco Financial Tower in Ho Chi Minh City. The group operates through three manufacturing subsidiaries (TV.PHARM, MEBIPHAR, S.PHARM), an R&D center (ALPHA LAB), and a distribution arm (ALPHA TRADE), serving consumers, pharmacies, hospitals, and government health programs across Vietnam with a portfolio of more than 400 products across pain relief, antibiotics, cardiovascular, diabetes, respiratory, digestive, and health supplement categories.

The manufacturing backbone includes the AIKYA EUROPA plant in Tra Vinh province, producing non-beta-lactam tablets, film-coated tablets, and hard capsules at approximately 1.5 billion units annual capacity under EU-GMP standards, with broader facility certifications covering GMP-WHO, FDA, and PIC/S. Aikya is developing Vietnam's largest high-tech pharmaceutical industrial cluster in Tra Vinh, with 400 billion VND invested across nearly 10 hectares, targeting 3.5 billion units annual capacity upon completion. A 2024 strategic cooperation with CSPC Pharmaceutical Group (ranked 30th globally) provides access to international pharmaceutical science and technology capabilities.

Revenue is generated predominantly through branded generic and OTC product sales to a pharmacy network distributed across all 63 Vietnamese provinces via 22+ Alpha Trade branches and a 400+ person medical representative field force, with secondary revenue from API and pharmaceutical raw material trading through Alpha Trade to other manufacturers. International exports currently reach six countries (Cambodia, Yemen, Afghanistan, Azerbaijan, Myanmar, and Djibouti), with an explicit $10 million USD export revenue target by 2028. The company is privately held with no external institutional investment evidenced, led by CEO Nguyễn Đắc Hải, and in June 2025 launched an internal AI project for business operations and management as the start of a formal digital transformation.

Name

Aikya

Legal name

Aikya Pharmaceutical Joint Stock Company

Website

https://aikya.vn

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Aikya Pharmaceutical Joint Stock Company is a Vietnamese vertically integrated pharmaceutical group manufacturing and distributing 400+ generic and branded pharmaceutical products across Vietnam through three manufacturing subsidiaries, an R&D center, and a 22-branch nationwide distribution network, targeting domestic pharmacy and healthcare channels plus six export markets.

Ownership category

akta.pro rank

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of manufactured pharmaceuticals including pain relievers, antibiotics, cardiovascular drugs, diabetes treatments, respiratory products, digestive treatments, and health supplements through TV.PHARM, MEBIPHAR, and S.PHARM brands.
2. Distribution Services: Alpha Trade serves as both internal distribution arm and external supplier of pharmaceutical raw materials (API) to other manufacturers, operating under GSP/GDP standards with international trade presence in 6 countries.
3. Medical Device Sales: Sale of medical devices including Mebiphar 3D Medical Mask and other healthcare products.
4. Health Supplement Sales: Sale of health supplements including Phariton TVP and other wellness products.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Aikya is a vertically integrated Vietnamese pharmaceutical group that manufactures, distributes, and markets pharmaceutical products, medical devices, and health supplements through its wholly-owned subsidiaries TV.PHARM, MEBIPHAR, and S.PHARM. The company operates EU-GMP certified manufacturing facilities, including the AIKYA EUROPA plant, supported by the ALPHA LAB R&D center and ALPHA TRADE distribution arm covering all 63 provinces in Vietnam. Its portfolio includes over 400 products across pain relief, antibiotics, cardiovascular, diabetes, respiratory, digestive, and supplement categories.

Product overview

Aikya is a Vietnamese pharmaceutical group offering a comprehensive product portfolio of over 400 items across pharmaceuticals, medical devices, and health supplements. The portfolio is organized through three main sub-brands: TV.PHARM (manufacturing, featuring pain relief products like Travicol, antibiotics like Orenko and Medolav, cardiovascular drugs like Glucofast, and digestive products like Suspengel), MEBIPHAR (biomedical products including the 3D Medical Mask), and S.PHARM (specializing in generics). Supporting infrastructure includes ALPHA LAB for R&D and ALPHA TRADE for distribution. The company operates the high-tech AIKYA EUROPA manufacturing facility and develops specialty products like the NuBo C supplement for children. Products span therapeutic categories including pain/fever relief, antibiotics, cardiovascular/diabetes treatments, respiratory, neurological, digestive, vitamins/supplements, and medical devices.

Differentiator

Problem solved

Functional benefit

Brands

• TV.PHARM: Core pharmaceutical manufacturing subsidiary producing pain relievers, fever reducers, antibiotics, cardiovascular and diabetes treatments
• MEBIPHAR
• S.PHARM
• ALPHA LAB
• ALPHA TRADE
• Travicol
• Suspengel
• Orenko
• Phariton TVP
• Glucofast
• AIKYA EUROPA
• NuBo

Products and services

• Travicol Pain reliever and fever reducer product line with multiple variants (Travicol 150, 250, 325, 500, 650, Extra, Flu, PA) including children's formulations; recognized as a Vietnam National Brand.
• Orenko Antibiotic pharmaceutical product that received the Vietnamese Medicine Star II award for quality and effectiveness; one of the leading antibiotic brands nationwide.
• Glucofast Anti-diabetic medication for managing blood sugar levels; showcased at Pharmedi Vietnam 2024 international exhibition.
• Suspengel Anti-inflammatory digestive support gel for soothing stomach discomfort; featured in community healthcare programs.
• Phariton TVP Health supplement product recognized with Vietnam National Brand award; featured in community health programs.
• Medolav EU-GMP standard antibiotic product used in community healthcare outreach programs across Vietnam.
• Mebiphar 3D Medical Mask Medical face mask product manufactured by MEBIPHAR subsidiary; honored with Vietnam National Brand recognition.
• NuBo C Vitamin C Supplement Vitamin C supplement candy for children available in orange and strawberry flavors, supporting immune system health; packaged in small sachets for easy carrying.

Quantifiable outcome

• 5 consecutive years ranked in Top 10 Reputable Pharmaceutical Manufacturers in Vietnam
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Quang Ngai Department of Health Youth UnionminorStrategic or Co-development Partner · 4 April 2026Partnership in the 'Young Physicians Following Uncle Ho's Teachings' program delivering healthcare services to over 300 residents in Dong Son Commune.
• Hong Duc General ClinicminorStrategic or Co-development Partner · 22 March 2026Partnership for community healthcare outreach in Ca Mau province, providing medical examinations and free medicine to over 120 underprivileged residents.
• Tam Tri Hong Ngu International HospitalminorStrategic or Co-development Partner · 21 March 2026Collaboration for community healthcare outreach in Dong Thap province, providing specialized medical check-ups, ultrasound services, testing, and free medicine distribution for over 250 local residents.
• Daisy MediaminorGTM or Marketing Partner · 14 October 2025Collaboration with Daisy Media and AloBacsi for the charity program 'For Beloved Northern Vietnam – Standing with Thai Nguyen Overcoming Floods', distributing medicines and medical supplies.
• AloBacsiminorGTM or Marketing Partner · 14 October 2025Partnership with Daisy Media and AloBacsi for flood relief charity campaign, supporting communities affected by Typhoon in Northern Vietnam.
• CSPC Pharmaceutical GroupcoreStrategic or Co-development Partner · 1 August 2025Strategic cooperation with CSPC, the 30th largest pharmaceutical group globally. Aikya partnered with CSPC for science and technology leadership in comprehensive healthcare, combining Aikya's Vietnamese market expertise with CSPC's global pharmaceutical capabilities.
• Nexus Sport EventsminorGTM or Marketing Partner · 13 April 2025Co-organizer of Aikya Cross Country Marathon 2025, a professional running event attracting nearly 4,300 runners. Nexus Sport Events brings 10+ years of experience in organizing sports events in Vietnam.
• Bac Trung Nam Charity ClubminorGTM or Marketing Partner · 1 September 2024Collaboration for '10,000 Flood Relief Medicine Packs' campaign providing essential medications to communities affected by Typhoon Yagi in Northern Vietnam.

Scale indicators15 records

Recent moves8 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/aikyapharma
• TikToktiktok.com/@aikyapharma

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aikya